Literature DB >> 12019171

Cooperative function of Aml1-ETO corepressor recruitment domains in the expansion of primary bone marrow cells.

Bruce A Hug1, Samuel Y D Lee, Erron L Kinsler, Jinsong Zhang, Mitchell A Lazar.   

Abstract

AML1-ETO is an oncoprotein that can promote self-renewal of primary hematopoietic cells by opposing the activity of AML1. Two domains, Nervy-homology(NH) 2 and NH4, have been implicated in the recruitment of corepressors by AML1-ETO, but the relative roles of NH2 and NH4 vary in different cell lines and have not been examined in nonimmortalized cells. Here, we have used a series of differentiation, proliferation, and self-renewal assays in an effort to determine the roles of the NH domains using progenitor-enriched primary bone marrow cells. In these assays, deletion of NH2 or NH4, individually, has a minimal effect on AML1-ETO function, and the mutants retain the ability to promote long-term expansion of cells. In contrast, the double deletion of NH2 and NH4 eliminates the activity of the fusion protein. Thus, the double deletion of NH2 and NH4 produces a functional deficit greater than the sum of the individual deletions. These findings suggest that the NH2 and NH4 domains function cooperatively in the corepressor environment of primary bone marrow cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12019171

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  15 in total

1.  New insights into transcriptional and leukemogenic mechanisms of AML1-ETO and E2A fusion proteins.

Authors:  Jian Li; Chun Guo; Nickolas Steinauer; Jinsong Zhang
Journal:  Front Biol (Beijing)       Date:  2016-09-03

2.  Structure of the AML1-ETO eTAFH domain-HEB peptide complex and its contribution to AML1-ETO activity.

Authors:  Sangho Park; Wei Chen; Tomasz Cierpicki; Marco Tonelli; Xiongwei Cai; Nancy A Speck; John H Bushweller
Journal:  Blood       Date:  2009-02-09       Impact factor: 22.113

3.  Structural basis for recognition of SMRT/N-CoR by the MYND domain and its contribution to AML1/ETO's activity.

Authors:  Yizhou Liu; Wei Chen; Justin Gaudet; Matthew D Cheney; Liya Roudaia; Tomasz Cierpicki; Rachel C Klet; Kari Hartman; Thomas M Laue; Nancy A Speck; John H Bushweller
Journal:  Cancer Cell       Date:  2007-06       Impact factor: 31.743

4.  The truncated RUNX1/ETO activates VLA-4-dependent adhesion and migration of hematopoietic progenitor cells.

Authors:  Kanagaraju Ponnusamy; Linping Chen-Wichmann; Olga N Kuvardina; Jörn Lausen; Reinhard Henschler; Christian Wichmann
Journal:  Haematologica       Date:  2014-08-08       Impact factor: 9.941

5.  Structure of the AML1-ETO NHR3-PKA(RIIα) complex and its contribution to AML1-ETO activity.

Authors:  Takeshi Corpora; Liya Roudaia; Zaw Min Oo; Wei Chen; Ekaterina Manuylova; Xiongwei Cai; Michael J Chen; Tomasz Cierpicki; Nancy A Speck; John H Bushweller
Journal:  J Mol Biol       Date:  2010-08-11       Impact factor: 5.469

6.  CBFbeta is critical for AML1-ETO and TEL-AML1 activity.

Authors:  Liya Roudaia; Matthew D Cheney; Ekaterina Manuylova; Wei Chen; Michelle Morrow; Sangho Park; Chung-Tsai Lee; Prabhjot Kaur; Owen Williams; John H Bushweller; Nancy A Speck
Journal:  Blood       Date:  2009-01-29       Impact factor: 22.113

7.  An activated receptor tyrosine kinase, TEL/PDGFbetaR, cooperates with AML1/ETO to induce acute myeloid leukemia in mice.

Authors:  Jay L Grisolano; Julie O'Neal; Jennifer Cain; Michael H Tomasson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-24       Impact factor: 11.205

8.  Transforming activity of AML1-ETO is independent of CBFbeta and ETO interaction but requires formation of homo-oligomeric complexes.

Authors:  Colin Kwok; Bernd B Zeisig; Jihui Qiu; Shuo Dong; Chi Wai Eric So
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-06       Impact factor: 11.205

Review 9.  Core binding factor at the crossroads: determining the fate of the HSC.

Authors:  Kevin A Link; Fu-Sheng Chou; James C Mulloy
Journal:  J Cell Physiol       Date:  2010-01       Impact factor: 6.384

10.  RUNX1/AML1 DNA-binding domain and ETO/MTG8 NHR2-dimerization domain are critical to AML1-ETO9a leukemogenesis.

Authors:  Ming Yan; Eun-Young Ahn; Scott W Hiebert; Dong-Er Zhang
Journal:  Blood       Date:  2008-11-25       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.